healthprotocol.wiki
Protocols
Evidence
Outcomes
Home
/
Evidence
aviles_2017_rct_prolonged-use-of-zoledronic-acid-4-years-did-not-improve-outcome-in-multiple-myeloma-patients
6 findings
Protocol
therapy-stem-cell-transplant-induction-zoledronic-acid-monthly-four-year
Outcome
oncology-skeletal-related-events-occurrence-rate-per-cohort-measured
n
84
effect
70
attribution
75
Protocol
therapy-stem-cell-transplant-induction-zoledronic-acid-monthly-two-year
Outcome
oncology-skeletal-related-events-occurrence-rate-per-cohort-measured
n
84
effect
-70
attribution
75
Protocol
therapy-stem-cell-transplant-induction-zoledronic-acid-monthly-four-year
Outcome
survival-overall-rate-at-5-years-proportion-cohort-measured
n
84
effect
0
attribution
75
Protocol
therapy-stem-cell-transplant-induction-zoledronic-acid-monthly-two-year
Outcome
survival-overall-rate-at-5-years-proportion-cohort-measured
n
84
effect
0
attribution
75
Protocol
therapy-stem-cell-transplant-induction-zoledronic-acid-monthly-four-year
Outcome
survival-progression-free-rate-at-5-years-proportion-cohort-measured
n
84
effect
5
attribution
75
Protocol
therapy-stem-cell-transplant-induction-zoledronic-acid-monthly-two-year
Outcome
survival-progression-free-rate-at-5-years-proportion-cohort-measured
n
84
effect
-5
attribution
75
